Staci Martin
National Cancer Center(US)National Cancer Institute(MY)National Cancer Institute(US)National Cancer Research Institute(GB)
Publications by Year
Research Areas
Neurofibromatosis and Schwannoma Cases, Neuroblastoma Research and Treatments, CAR-T cell therapy research, Glioma Diagnosis and Treatment, Hemoglobinopathies and Related Disorders
Most-Cited Works
- → CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy(2017)1,320 cited
- → CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial(2020)406 cited
- → Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL(2021)346 cited
- → CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR(2022)168 cited
- → Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas(2023)91 cited
- → Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels.(1991)89 cited